Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€7.80

€7.80

0.650%
0.05
0.650%
€12.00

€12.00

 
17:30 / Tradegate WKN: A11QVV / Name: Heidelberg Pharma / Stock / Biotechnology & Medical Research / Micro Cap /
Latest predictions
€12.00
25.03.21
buy
€10.00
21.02.21
buy
€15.00
18.02.21
buy
€8.00
27.01.21
buy
-
26.11.20
-
02.11.20
Your prediction

Heidelberg Pharma AG Stock

Heidelberg Pharma AG gained 0.650% compared to yesterday.
We see a rather positive sentiment for Heidelberg Pharma AG with 8 Buy predictions and 2 Sell predictions.
As a result the target price of €12.00 shows a very positive potential of 53.846% compared to the current price of €7.80 for Heidelberg Pharma AG.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Heidelberg Pharma AG stock. Negative votes have not been in the majority for any criteria for this stock

Pros and Cons of Heidelberg Pharma AG in the next few years

Pros
2
Could be worthwhile Investment >10% per year
1
Top 10 in its market
1
Future proof or reliable business model
Cons
0
-

Performance of Heidelberg Pharma AG vs. its peers

Security Change (%) 1w 1m 1y YTD 3y 5y
Heidelberg Pharma AG 0.650% -2.270% -0.386% 44.860% 13.304% 150.000% 312.453%
Nanorepro AG -6.670% -8.618% -24.074% 376.744% 225.397% 748.276% 251.429%
Vivoryon Therapeutics N.V. -2.570% -0.672% 1.791% 260.928% 62.596% -31.099% -31.099%
Elanix Biotechnologies AG -3.330% -3.333% -11.585% -4.605% -51.667% - -

Comments

Buy Heidelberg Pharma AG
Show more

Sell Heidelberg Pharma AG
Show more

Other discussions about Heidelberg Pharma AG Stock

Trading Heidelberg Pharma AG

Trading Heidelberg Pharma AG

New thread Forum

News

DGAP-News: Heidelberg Pharma will Present at German Equity Forum and Provides Update on Partner Activities for its Legacy Assets
DGAP-News: Heidelberg Pharma will Present at German Equity Forum and Provides Update on Partner Activities for its Legacy Assets
DGAP-News: Heidelberg Pharma Announces Several Presentations of Research Results on ATAC Technology at the ASH Annual Meeting 2020
DGAP-News: Heidelberg Pharma Announces Several Presentations of Research Results on ATAC Technology at the ASH Annual Meeting 2020